UNSPSC 51112515: Mannomustine dihydrochloride

This classification denotes a nitrogen mustard compound with the molecular formula C10H22Cl2N2O4.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UOZ2JJZ3I5, chemically known as d-mannitol, 1,6-bis((2-chloroethyl)amino)-1,6-dideoxy-, dihydrochloride, but more generally known as mannomustine dihydrochloride, which bears US NIH Compound Identifier 11337. European Medicines Agency schedules mannomustine dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08643MIG.

Most nations, for tariff purposes, schedule mannomustine dihydrochloride under HS 29221980. SMILES: C(CCL)NC[C@H]([C@H]([C@@H]([C@@H](CNCCCL)O)O)O)O.CL.CL.

UNSPSC 51112515 Mannomustine dihydrochloride is a Commodity code covering a specialized pharmaceutical compound used in cancer treatment and research applications that state and local health systems and medical institutions procure. State and local governments source this drug primarily through public health departments, state Medicaid agencies, university medical centers, and county hospital systems that maintain oncology and chemotherapy programs. The procurement activity under this code is minimal in the public records available, reflecting both the specialized nature of the drug and the fact that most state and local acquisition of such pharmaceuticals flows through established group purchasing organizations, state pharmaceutical contracts, and federal supply schedules rather than direct, individual solicitations.

The source provides no recent state and local contract opportunities, RFP notices, or issuing-body activity specifically tagged to this code. Without posted solicitations naming the drug, issuing jurisdiction, notice type, or response dates, no geographic concentration or representative opportunity detail can be established from available records.